Format

Send to:

Choose Destination
See comment in PubMed Commons below
Horm Metab Res. 2003 Nov-Dec;35(11-12):857-71.

The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?

Author information

  • 1Receptor Biology Laboratory, Hagedorn Research Institute, Gentofte, Denmark. stvg@novonordisk.com

Erratum in

  • Horm Metab Res. 2004 Jan;36(1):74.

Abstract

There is compelling evidence from epidemiological studies in humans, as well as in vitro and in vivo experimental observations including transgenic animal models, for a role of the IGF/insulin signalling system in cancer tumourigenesis. In this review focused on breast cancer, we review the experimental evidence, discuss the cellular and molecular mechanisms of tumourigenicity by the IGFs and insulin and various possible therapeutic strategies based on the mechanisms discussed.

PMID:
14710369
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Write to the Help Desk